tradingkey.logo

NovaBay jumps after $6 million investment, new CEO

ReutersAug 19, 2025 9:52 PM

Shares of NovaBay Pharmaceuticals NBY.A soar 75% to $1.02 after the bell

NBY says it has entered into a $6 million securities purchase agreement with private investor David Lazar

Lazar has also been appointed NBY's CEO, effective immediately

NBY says it intends to use the proceeds from the investment to pursue a strategic investment and/or an acquisition

Company also expects to declare a special cash dividend in Q3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI